Nanotechnology in Medicine – Thematic Research
- Pages: 28
- Published: June 2020
- Report Code: GDHC-HT-147
Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. These materials are produced on a nanoscale level and are safe to introduce into the body. Applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases. In addition to targeted delivery of therapeutics, nanotechnology can also be used to release drugs in a controlled manner. This can result in improved outcomes for patients due to a reduction in toxicity, more efficient delivery of therapeutic molecules, and longer lifetime of drugs within the body.
This is a single theme report providing in-house analyst expertise of nanotechnology in medicine.
Components of the report include:
Key Players — identify big players in nanomedicine.
Trends — identify key trends expected to occur in the nanotechnology industry over the next 12 to 24 months. These are classified into technology/scientific trends, macroeconomic trends, and regulatory trends.
Industry Analysis — identify the impact of nanotechnology across major markets.
Value Chain – identify the various uses of nanotechnologies in medicine.
This report focuses on nanotechnology and nanomedicines that are currently approved by the FDA.
Reasons to buy
Develop and design your corporate strategies through an in-house expert analysis of nanotechnology and the impact on medicine.
Develop business strategies by understanding the primary ways in which nanotechnology is changing the delivery of medicine.
Stay up to date on the industry’s major players in nanotechnology and where they sit in the value chain.
Identify emerging industry trends in nanotechnology to gain a competitive advantage.
Bausch Health Companies Inc
Eisai Co Ltd
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
Jazz Pharmaceuticals Plc
Lantheus Holdings Inc
Merck & Co Inc
Novo Nordisk AS
Pacira BioSciences Inc
Takeda Pharmaceutical Co Ltd
Dompe Farmaceutici SpA
GE Healthcare LLC
Janssen Pharmaceuticals Inc
Table of Contents
COVID-19 Impact on nanotechnology in medicine
Appendix: Our thematic research methodology